PHStrader
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

PHStrader

Forum Replies Created

Viewing 3 reply threads
  • Replies
      • December 2, 2010 at 2:35 am
      PHStrader
      Participant

      I have been researching melanoma drugs for the last six months and based on what I have found PV-10 looks to be one of the more promissing investigational new melanoma drugs currently being tested in FDA / TGA trials right now. Based on the published Phase 2 results it looks like PV-10 works as well or better than any of the other new melanoma drugs. Objective and Complete response results are better than the other new melanoma drugs and from what I have read the side effects are minimal to moderate. Provectus Pharmaceuticals currently has over 40 patients enrolled in the PV-10 compassionate use program and is in discussion with the FDA designing their Phase 3 trial. I would definately look into PV-10 as an option.  http://www.pvct.com

      Dennis

      • December 2, 2010 at 2:35 am
      PHStrader
      Participant

      I have been researching melanoma drugs for the last six months and based on what I have found PV-10 looks to be one of the more promissing investigational new melanoma drugs currently being tested in FDA / TGA trials right now. Based on the published Phase 2 results it looks like PV-10 works as well or better than any of the other new melanoma drugs. Objective and Complete response results are better than the other new melanoma drugs and from what I have read the side effects are minimal to moderate. Provectus Pharmaceuticals currently has over 40 patients enrolled in the PV-10 compassionate use program and is in discussion with the FDA designing their Phase 3 trial. I would definately look into PV-10 as an option.  http://www.pvct.com

      Dennis

      • December 2, 2010 at 2:35 am
      PHStrader
      Participant

      I have been researching melanoma drugs for the last six months and based on what I have found PV-10 looks to be one of the more promissing investigational new melanoma drugs currently being tested in FDA / TGA trials right now. Based on the published Phase 2 results it looks like PV-10 works as well or better than any of the other new melanoma drugs. Objective and Complete response results are better than the other new melanoma drugs and from what I have read the side effects are minimal to moderate. Provectus Pharmaceuticals currently has over 40 patients enrolled in the PV-10 compassionate use program and is in discussion with the FDA designing their Phase 3 trial. I would definately look into PV-10 as an option.  http://www.pvct.com

      Dennis

      • December 2, 2010 at 2:35 am
      PHStrader
      Participant

      I have been researching melanoma drugs for the last six months and based on what I have found PV-10 looks to be one of the more promissing investigational new melanoma drugs currently being tested in FDA / TGA trials right now. Based on the published Phase 2 results it looks like PV-10 works as well or better than any of the other new melanoma drugs. Objective and Complete response results are better than the other new melanoma drugs and from what I have read the side effects are minimal to moderate. Provectus Pharmaceuticals currently has over 40 patients enrolled in the PV-10 compassionate use program and is in discussion with the FDA designing their Phase 3 trial. I would definately look into PV-10 as an option.  http://www.pvct.com

      Dennis

      • December 6, 2010 at 2:05 pm
      PHStrader
      Participant

      Hello Lynn.

      I checked with Provectus Pharmaceuticals and asked them if patients with auto immune diseases…like rheumatoid arthritus could qualify for their PV-10 Phase 3 Trial or their Compassionate Use Program and this is the answer I received.  I hope this helps. Have a great day!

      Dennis, I’ve checked with Eric Wachter who runs our clinical trial programs.  He says “This is not a current exclusion criterion.”  So, the answer to your question is “yes.”

      Please let me know of anything else.

      Thanks!

      Pete

      Peter R. Culpepper, CFO, COO
      Provectus Pharmaceuticals, Inc.
      7327 Oak Ridge Highway
      Knoxville, TN 37931 USA
      O:  866.594.5999 ext. 30
      M:  865.235.5485
      F:  866.998.0005
      culpepper@pvct.com; http://www.pvct.com
       

      • December 6, 2010 at 2:05 pm
      PHStrader
      Participant

      Hello Lynn.

      I checked with Provectus Pharmaceuticals and asked them if patients with auto immune diseases…like rheumatoid arthritus could qualify for their PV-10 Phase 3 Trial or their Compassionate Use Program and this is the answer I received.  I hope this helps. Have a great day!

      Dennis, I’ve checked with Eric Wachter who runs our clinical trial programs.  He says “This is not a current exclusion criterion.”  So, the answer to your question is “yes.”

      Please let me know of anything else.

      Thanks!

      Pete

      Peter R. Culpepper, CFO, COO
      Provectus Pharmaceuticals, Inc.
      7327 Oak Ridge Highway
      Knoxville, TN 37931 USA
      O:  866.594.5999 ext. 30
      M:  865.235.5485
      F:  866.998.0005
      culpepper@pvct.com; http://www.pvct.com
       

Viewing 3 reply threads
About the MRF Patient Forum

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

Popular Topics